Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35590 | 95 | 36.8 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
246 | 3 | SUPERHYDROPHOBIC//SUPERHYDROPHOBICITY//PICKERING EMULSION | 46848 |
1357 | 2 | SUPERHYDROPHOBIC//SUPERHYDROPHOBICITY//OIL WATER SEPARATION | 8277 |
35590 | 1 | ANTICANC MOL ONCOL//PRO APOPTOTIC H RAS//BUPRENORPHINE HYDROCHLORIDE | 95 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTICANC MOL ONCOL | address | 2592845 | 12% | 73% | 11 |
2 | PRO APOPTOTIC H RAS | authKW | 964283 | 3% | 100% | 3 |
3 | BUPRENORPHINE HYDROCHLORIDE | authKW | 892850 | 5% | 56% | 5 |
4 | PTO O ACACGAMMA ACACDMS | authKW | 723211 | 3% | 75% | 3 |
5 | NOX 1 | authKW | 642851 | 4% | 50% | 4 |
6 | APOPTOTIC CYTOKINES | authKW | 321428 | 1% | 100% | 1 |
7 | COMPLEX DIPICOLYLAMINE | authKW | 321428 | 1% | 100% | 1 |
8 | DIFFERENTIAL DISPLAY CLONING | authKW | 321428 | 1% | 100% | 1 |
9 | ERR PATHWAY | authKW | 321428 | 1% | 100% | 1 |
10 | H2O2 ACTIVATABLE | authKW | 321428 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 169 | 23% | 0% | 22 |
2 | Pharmacology & Pharmacy | 157 | 25% | 0% | 24 |
3 | Chemistry, Inorganic & Nuclear | 87 | 12% | 0% | 11 |
4 | Toxicology | 83 | 9% | 0% | 9 |
5 | Biophysics | 67 | 11% | 0% | 10 |
6 | Biochemistry & Molecular Biology | 47 | 22% | 0% | 21 |
7 | Cell Biology | 43 | 13% | 0% | 12 |
8 | Medicine, Research & Experimental | 11 | 5% | 0% | 5 |
9 | Microscopy | 7 | 1% | 0% | 1 |
10 | Materials Science, Biomaterials | 2 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTICANC MOL ONCOL | 2592845 | 12% | 73% | 11 |
2 | IST GENET MOL BIOL CELLULARE NEUROBIOL | 321428 | 1% | 100% | 1 |
3 | TECNOL BIOL AMBIENTALI | 321428 | 1% | 100% | 1 |
4 | CONSORTIUM CARSO | 214282 | 2% | 33% | 2 |
5 | CELL REGULAT | 194383 | 16% | 4% | 15 |
6 | VANDERBILT INGRAM CANC CELL BIOL | 160713 | 1% | 50% | 1 |
7 | DIPARTIMENTO AMBIENTALI | 107141 | 1% | 33% | 1 |
8 | NUTRIGEN VASC BIOL | 107141 | 1% | 33% | 1 |
9 | DI S TE BA | 107139 | 2% | 17% | 2 |
10 | BIOL PHARMACEUT SCI | 91027 | 7% | 4% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF HEALTH SCIENCE | 1025 | 2% | 0% | 2 |
2 | BIOLOGICAL & PHARMACEUTICAL BULLETIN | 930 | 5% | 0% | 5 |
3 | UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 903 | 1% | 0% | 1 |
4 | CHINESE JOURNAL OF INORGANIC CHEMISTRY | 851 | 4% | 0% | 4 |
5 | NATURE REVIEWS UROLOGY | 724 | 1% | 0% | 1 |
6 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 598 | 3% | 0% | 3 |
7 | CELL DEATH & DISEASE | 542 | 2% | 0% | 2 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 448 | 5% | 0% | 5 |
9 | DNA SEQUENCE | 347 | 1% | 0% | 1 |
10 | SCIENCE CHINA-LIFE SCIENCES | 338 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRO APOPTOTIC H RAS | 964283 | 3% | 100% | 3 | Search PRO+APOPTOTIC+H+RAS | Search PRO+APOPTOTIC+H+RAS |
2 | BUPRENORPHINE HYDROCHLORIDE | 892850 | 5% | 56% | 5 | Search BUPRENORPHINE+HYDROCHLORIDE | Search BUPRENORPHINE+HYDROCHLORIDE |
3 | PTO O ACACGAMMA ACACDMS | 723211 | 3% | 75% | 3 | Search PTO+O+ACACGAMMA+ACACDMS | Search PTO+O+ACACGAMMA+ACACDMS |
4 | NOX 1 | 642851 | 4% | 50% | 4 | Search NOX+1 | Search NOX+1 |
5 | APOPTOTIC CYTOKINES | 321428 | 1% | 100% | 1 | Search APOPTOTIC+CYTOKINES | Search APOPTOTIC+CYTOKINES |
6 | COMPLEX DIPICOLYLAMINE | 321428 | 1% | 100% | 1 | Search COMPLEX+DIPICOLYLAMINE | Search COMPLEX+DIPICOLYLAMINE |
7 | DIFFERENTIAL DISPLAY CLONING | 321428 | 1% | 100% | 1 | Search DIFFERENTIAL+DISPLAY+CLONING | Search DIFFERENTIAL+DISPLAY+CLONING |
8 | ERR PATHWAY | 321428 | 1% | 100% | 1 | Search ERR+PATHWAY | Search ERR+PATHWAY |
9 | H2O2 ACTIVATABLE | 321428 | 1% | 100% | 1 | Search H2O2+ACTIVATABLE | Search H2O2+ACTIVATABLE |
10 | IMAGING CANCER | 321428 | 1% | 100% | 1 | Search IMAGING+CANCER | Search IMAGING+CANCER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE PASCALI, SA , MUSCELLA, A , VETRUGNO, C , MARSIGLIANTE, S , FANIZZI, FP , (2014) SYNTHESIS, CHARACTERIZATION AND CYTOTOXICITY OF NOVEL PT(II) KAPPA O-2,O '-ACETYLACETONATE COMPLEXES WITH NITROGEN LIGANDS.INORGANICA CHIMICA ACTA. VOL. 412. ISSUE . P. 88 -93 | 10 | 48% | 3 |
2 | MUSCELLA, A , VETRUGNO, C , COSSA, LG , ANTONACI, G , DE NUCCIO, F , DE PASCALI, SA , FANIZZI, FP , MARSIGLIANTE, S , (2016) IN VITRO AND IN VIVO ANTITUMOR ACTIVITY OF [PT (O,O'-ACAC)(GAMMA-ACAC)(DMS)] IN MALIGNANT PLEURAL MESOTHELIOMA.PLOS ONE. VOL. 11. ISSUE 11. P. - | 13 | 32% | 0 |
3 | CHOUDHARY, S , WANG, KKA , WANG, HCR , (2011) ONCOGENIC H-RAS, FK228, AND EXOGENOUS H2O2 COOPERATIVELY ACTIVATED THE ERK PATHWAY IN SELECTIVE INDUCTION OF HUMAN URINARY BLADDER CANCER J82 CELL DEATH.MOLECULAR CARCINOGENESIS. VOL. 50. ISSUE 3. P. 215 -219 | 7 | 58% | 5 |
4 | KOHNO, M , TANIMURA, S , OZAKI, K , (2011) TARGETING THE EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAY IN CANCER THERAPY.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 34. ISSUE 12. P. 1781 -1784 | 8 | 31% | 30 |
5 | MUSCELLA, A , VETRUGNO, C , BIAGIONI, F , CALABRISO, N , CALIERNO, MT , FORNAI, F , DE PASCALI, SA , MARSIGLIANTE, S , FANIZZI, FP , (2016) ANTITUMOUR AND ANTIANGIOGENIC ACTIVITIES OF [PT(O,O '-ACAC)(GAMMA-ACAC)(DMS)] IN A XENOGRAFT MODEL OF HUMAN RENAL CELL CARCINOMA.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 173. ISSUE 17. P. 2633 -2644 | 10 | 21% | 1 |
6 | YANG, X , CHEN, QY , SONG, JB , (2012) TUMOR-IMAGING CORE-SHELL NANO-MODELS FOR CATALASE.CHINESE JOURNAL OF INORGANIC CHEMISTRY. VOL. 28. ISSUE 1. P. 164 -170 | 6 | 38% | 2 |
7 | MUSCELLA, A , VETRUGNO, C , CALABRISO, N , COSSA, LG , DE PASCALI, SA , FANIZZI, FP , MARSIGLIANTE, S , (2014) [PT(O,O '-ACAC)(GAMMA-ACAC)(DMS)] ALTERS SH-SY5Y CELL MIGRATION AND INVASION BY THE INHIBITION OF NA+/H+ EXCHANGER ISOFORM 1 OCCURRING THROUGH A PKC-EPSILON/ERK/MTOR PATHWAY.PLOS ONE. VOL. 9. ISSUE 11. P. - | 10 | 20% | 7 |
8 | MUSCELLA, A , VETRUGNO, C , MIGONI, D , BIAGIONI, F , FANIZZI, FP , FORNAI, F , DE PASCALI, SA , MARSIGLIANTE, S , (2014) ANTITUMOR ACTIVITY OF [PT(O,O '-ACAC)(GAMMA-ACAC)(DMS)] IN MOUSE XENOGRAFT MODEL OF BREAST CANCER.CELL DEATH & DISEASE. VOL. 5. ISSUE . P. - | 6 | 27% | 6 |
9 | DE PASCALI, SA , MUSCELLA, A , MARSIGLIANTE, S , BOTTONE, MG , BERNOCCHI, G , FANIZZI, FP , (2013) CISPLATIN-RELATED DRUGS FOR NONGENOMIC TARGETS: FORCING THE REACTIVITY WITH NUCLEOBASES.PURE AND APPLIED CHEMISTRY. VOL. 85. ISSUE 2. P. 355-364 | 7 | 25% | 1 |
10 | MUSCELLA, A , VETRUGNO, C , FANIZZI, FP , MANCA, C , DE PASCALI, SA , MARSIGLIANTE, S , (2013) A NEW PLATINUM(II) COMPOUND ANTICANCER DRUG CANDIDATE WITH SELECTIVE CYTOTOXICITY FOR BREAST CANCER CELLS.CELL DEATH & DISEASE. VOL. 4. ISSUE . P. - | 7 | 23% | 8 |
Classes with closest relation at Level 1 |